Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects
暂无分享,去创建一个
J. Schoepfer | Imad Hanna | F. Hourcade‐Potelleret | Xianbin Tian | T. Ray | B. Zhu | H. Einolf | Lai Wang | Phi Tran | F. Eggimann | Petra Priess